SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-073731
Filing Date
2022-06-23
Accepted
2022-06-23 07:38:43
Documents
4
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2217325d4_6k.htm 6-K 12462
2 EXHIBIT 99.1 tm2217325d4_ex99-1.htm EX-99.1 18785
3 GRAPHIC tm2217325d4_ex99-1img001.jpg GRAPHIC 230921
4 GRAPHIC tm2217325d4_ex99-1img002.jpg GRAPHIC 67470
  Complete submission text file 0001104659-22-073731.txt   437319
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 221033582
SIC: 2836 Biological Products, (No Diagnostic Substances)